Johnson & Johnson and Stryker are identified as legacy incumbents advancing platforms in the surgical robotics market.

1 report, 1 independent Updated Jul 11

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Stryker Corporation Johnson & Johnson

Keep exploring

Part of

Domination in medical technology industry involving Intuitive Surgical, Johnson & Johnson, and Stryker.

Also in this story

Intuitive Surgical and Johnson & Johnson are competing in the robotic surgery market, with J&J maintaining a global office in Santa Clara.Jul 22

All 4 developments

The entities involved

Stryker Corporation
American medical technologies company

Nothing else this week.
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- UK approved Johnson & Johnson's oral psoriasis treatment, and Amundi increased its holdings in J&J shares.09:51
- MarketBeat listed Johnson & Johnson, AbbVie, Pfizer, Merck KGaA, Eli Lilly, Gilead Sciences, and Novartis as stocks to watch.Sat 22:36

Related events

Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Sep 27

Coverage

Newest first; wire copies grouped

Jul 11GlobeNewswireNew PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who’s actu